DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Otros (Other)
Simulating the impact of non-pharmaceutical interventions limiting transmission in COVID-19 epidemics using a membrane computing model
Epidemics caused by microbial organisms are part of the natural phenomena of increasing biological complexity. The heterogeneity and constant variability of hosts, in terms of age, immunological status, family structure, lifestyle, work activities, social and leisure habits, daily division of time, and other demographic characteristics make it extremely difficult to predict the evolution of epidemics. Such prediction is, however, critical for implementing intervention measures in due time and with appropriate intensity. General conclusions should be precluded, given that local parameters dominate the flow of local epidemics. Membrane computing models allows us to reproduce the objects (viruses, hosts) and their interactions (stochastic but also with defined probabilities) with an unprecedented level of detail. Our LOIMOS model helps reproduce the demographics and social aspects of a hypothetical town of 10,320 inhabitants in an average European country where COVID-19 is imported from the outside. The above-mentioned characteristics of hosts and their lifestyle are minutely considered. The dynamics of the epidemics are reproduced and include the effects on viral transmission of innate and acquired immunity at various ages. The model predicts the consequences of delaying the adoption of non-pharmaceutical interventions (between 15 and 45 days after the first reported cases) and the effect of those interventions on infection and mortality rates (reducing transmission by 20%, 50%, and 80%) in immunological response groups. The lockdown for the elderly population as a single intervention appears to be effective. This modelling exercise exemplifies the application of membrane computing for designing appropriate interventions in epidemic situations., MC and FB were sponsored by the Projects COV20_00067 of the Program SARS-COV-2 and COVID-19 infection of the Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación of Spain, CB06/02/0053 of the Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), and the Regional Government of Madrid (InGeMICS-B2017/BMD-3691). For JCG, this study was partially founded by the Autonomous Community of Madrid, Spain (COVID-19 Grant, 2020) and the Ramón y Cajal Institute for Health Research (IRYCIS), Madrid, Spain. For AM, this study was supported by grants from the Spanish Ministry of Science and Innovation (PID2019-105969GB-I00), the government of Valencia (project Prometeo/2018/A/133) and cofinanced by the European Regional Development Fund (ERDF)., No